We are live on ! Find out more
CANF

Can-Fite BioPharma American Depositary Shares
CANF

2 hedge funds and large institutions have $416K invested in Can-Fite BioPharma American Depositary Shares in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

66% less capital invested

Capital invested by funds: $1.22M → $416K (-$800K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$803K
2
BRWA
B. Riley Wealth Advisors
Florida
-$3.57K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
1
Deutsche Bank
Germany
$382K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$33K -$803K -71 -96%
Ameriprise
3
Ameriprise
Minnesota
$1K – – –
BRWA
4
B. Riley Wealth Advisors
Florida
– -$3.57K – –

CANF Hedge Fund Activity: Q3 2014 in Review

2 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2014, worth a combined $416K — down 66% from $1.22M a quarter earlier.

Fund positioning in CANF was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $803K.

  • 2 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $416K of Can-Fite BioPharma American Depositary Shares stock for Q3 2014, down 66% quarter-over-quarter.
  • 0 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2014 and 0 closed out.
  • The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2014 was Susquehanna International Group, an estimated $803K sold.

Based on aggregated 13F filings for Q3 2014.